We focused on mutations linked to discrete brain regions and key biological pathways altered in DMGs, including mutations specific to thalamic and brainstem tumors and affecting receptor tyrosine kinases; BMP, PI3K/mTOR, and MAPK signaling; the cell cycle; and DNA repair. The gene discussed is MTOR; the disease is brainstem neoplasm.